We serve Chemical Name:1-Bromo-2,3,4,5-tetramethoxy-6-methylbenzene CAS:73875-27-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-Bromo-2,3,4,5-tetramethoxy-6-methylbenzene
CAS.NO:73875-27-1
Synonyms:1-bromo-2-methyl-3,4,5,6-tetramethoxybenzene;1,2,3,4-tetramethoxy-5-methyl-6-bromobenzene;2,3,4,5-tetramethoxy-6-methyl bromo benzene;2,3,4,5-tetramethoxy-6-methyl-1-bromobenzene;Benzene, 1-bromo-2,3,4,5-tetramethoxy-6-methyl-;2-methyl-3,4,5,6-tetramethoxybromobenzene;2-bromo-3,4,5,6-tetramethoxytoluene;1-Bromo-2,3,4,5-tetramethoxy-6-methylbenzene;MFCD08458461
Molecular Formula:C11H15BrO4
Molecular Weight:291.138
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:317.0±37.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.513
PSA:36.92000
Exact Mass:290.015350
LogP:2.94
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-bromo-2-methyl-3,4,5,6-tetramethoxybenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD08458461 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3,4,5-tetramethoxy-6-methyl-1-bromobenzene Use and application,2-bromo-3,4,5,6-tetramethoxytoluene technical grade,usp/ep/jp grade.
Related News: Wavelength, a more than 30-year-old firm based in Petah Tikva, launched its API CDMO business in early 2020 and currently sports more than 250 customers from 50 countries. N-(4-fluoro-benzyl)-4-isopropyl-6-(3-trifluoromethoxy-phenylamino)-nicotinamide manufacturers The relationship between a CDMO and the company also depends on influencing aspects such as transparent communication, involvement at every step, and support while dealing with challenges. 4-Chloro-N-hydroxy-thiobenzimidic acid 2-hydroxy-ethyl ester suppliers Joan Merrill, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Research Program, US, said: “Arthritis and rash are the most common and persistent problems in lupus and often have a significant impact on a person’s life. The strength of the data from this analysis is that anifrolumab was found to be consistently effective using three different ways of looking at rash and three different approaches to arthritis. 4,6-dihydroxy-34,44,54,64,81-octaoxida-4,5-dien-3-one vendor & factory.
